Akebia Therapeutics, Inc. License Agreements

8 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment #1 to Second Amended and Restated License Agreement, dated May 3, 2024, by and between the Company and Vifor (International) Ltd
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
2024
Amendment #1 to License Agreement, dated August 30, 2024, by and among Akebia Therapeutics, Inc., Keryx Biopharmaceuticals, Inc. and Averoa SAS
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
2024
License Agreement, dated May 24, 2023, by and between the Company and MEDICE Arzneimittel Ptter GmbH & Co. KG
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2023
License Agreement, dated December 22, 2022, by and among Akebia Therapeutics, Inc., Keryx Biopharmaceuticals, Inc. and Averoa SAS
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2023
Second Amended and Restated License Agreement, dated
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2022
Amended and Restated License Agreement, dated as of April 8, 2019, by and between Akebia Therapeutics, Inc. and Vifor (International) Ltd
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2019
Second Amended and Restated License Agreement, dated as of April 17, 2019, by and between Akebia Therapeutics, Inc. and Panion & BF Biotech, Inc
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
NY
2019
CONFIDENTIAL RESEARCH AND LICENSE AGREEMENT between AKEBIA THERAPEUTICS, INC. and Janssen Pharmaceutica NV Dated as of February 9, 2017
License Agreements
Akebia Therapeutics, Inc.
Biotechnology
DE
2017